These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26690735)

  • 21. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein.
    Cady S; Wang T; Hong M
    J Am Chem Soc; 2011 Aug; 133(30):11572-9. PubMed ID: 21661724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel].
    Vorobjev YN
    Mol Biol (Mosk); 2020; 54(2):321-332. PubMed ID: 32392203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the proton conductance and drug resistance of BM2 channel through molecular dynamics simulations and free energy calculations at different pH conditions.
    Zhang Y; Shen H; Zhang M; Li G
    J Phys Chem B; 2013 Jan; 117(4):982-8. PubMed ID: 23286443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Silico Analysis Revealed a Unique Binding but Ineffective Mode of Amantadine to Influenza Virus B M2 Channel.
    Zhang Y; Zheng QC
    J Phys Chem Lett; 2021 Feb; 12(4):1169-1174. PubMed ID: 33480694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
    Gleed ML; Busath DD
    J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the function and inhibition of an influenza virus proton channel.
    Stouffer AL; Acharya R; Salom D; Levine AS; Di Costanzo L; Soto CS; Tereshko V; Nanda V; Stayrook S; DeGrado WF
    Nature; 2008 Jan; 451(7178):596-9. PubMed ID: 18235504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    Pan P; Li L; Li Y; Li D; Hou T
    Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus.
    Salom D; Hill BR; Lear JD; DeGrado WF
    Biochemistry; 2000 Nov; 39(46):14160-70. PubMed ID: 11087364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling influenza virus replication by inhibiting its proton channel.
    Pinto LH; Lamb RA
    Mol Biosyst; 2007 Jan; 3(1):18-23. PubMed ID: 17216051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
    Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
    Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel.
    Ma C; Polishchuk AL; Ohigashi Y; Stouffer AL; Schön A; Magavern E; Jing X; Lear JD; Freire E; Lamb RA; DeGrado WF; Pinto LH
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12283-8. PubMed ID: 19590009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine blocks channel activity of the transmembrane segment of the NB protein from influenza B.
    Fischer WB; Pitkeathly M; Sansom MS
    Eur Biophys J; 2001 Oct; 30(6):416-20. PubMed ID: 11718294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
    Khurana E; Devane RH; Dal Peraro M; Klein ML
    Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.
    Duff KC; Ashley RH
    Virology; 1992 Sep; 190(1):485-9. PubMed ID: 1382343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel method of resistance for influenza against a channel-blocking antiviral drug.
    Astrahan P; Kass I; Cooper MA; Arkin IT
    Proteins; 2004 May; 55(2):251-7. PubMed ID: 15048819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
    Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S
    Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.